학술논문

Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia
Document Type
article
Source
Breast Cancer Research. 22(1)
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Rare Diseases
Cancer
Human Genome
Breast Cancer
Genetics
Africa
BRCA1 Protein
Brazil
Breast Neoplasms
Chile
Chromosomes
Human
Pair 17
Colombia
Female
Founder Effect
Genetic Predisposition to Disease
Genome-Wide Association Study
Germ-Line Mutation
Haplotypes
Humans
Polymorphism
Single Nucleotide
Portugal
Spain
Breast cancer
Haplotype
BRCA1
c.3331_3334delCAAG
Founder mutation
Brazilian Familial Cancer Network
COLUMBUS Consortium
BRCA1 c.3331_3334delCAAG
Oncology & Carcinogenesis
Oncology and carcinogenesis
Language
Abstract
BackgroundThe BRCA1 c.3331_3334delCAAG founder mutation has been reported in hereditary breast and ovarian cancer families from multiple Hispanic groups. We aimed to evaluate BRCA1 c.3331_3334delCAAG haplotype diversity in cases of European, African, and Latin American ancestry.MethodsBC mutation carrier cases from Colombia (n = 32), Spain (n = 13), Portugal (n = 2), Chile (n = 10), Africa (n = 1), and Brazil (n = 2) were genotyped with the genome-wide single nucleotide polymorphism (SNP) arrays to evaluate haplotype diversity around BRCA1 c.3331_3334delCAAG. Additional Portuguese (n = 13) and Brazilian (n = 18) BC mutation carriers were genotyped for 15 informative SNPs surrounding BRCA1. Data were phased using SHAPEIT2, and identical by descent regions were determined using BEAGLE and GERMLINE. DMLE+ was used to date the mutation in Colombia and Iberia.ResultsThe haplotype reconstruction revealed a shared 264.4-kb region among carriers from all six countries. The estimated mutation age was ~ 100 generations in Iberia and that it was introduced to South America early during the European colonization period.ConclusionsOur results suggest that this mutation originated in Iberia and later introduced to Colombia and South America at the time of Spanish colonization during the early 1500s. We also found that the Colombian mutation carriers had higher European ancestry, at the BRCA1 gene harboring chromosome 17, than controls, which further supported the European origin of the mutation. Understanding founder mutations in diverse populations has implications in implementing cost-effective, ancestry-informed screening.